1. Market Research
  2. > Aprogen, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Summary

Aprogen, Inc. (Aprogen) is a Korea based biotechnology company. It is principally engaged in the development and production of monoclonal antibodies for the prevention and treatment of various human diseases through its advanced antibody, protein and animal cell engineering technologies. It conducts the development of biosimilars for antibody drugs with generic names such as Infliximab, Trastuzumab, and Rituximab among others. These drugs are yet to be commercialized as biopharmaceuticals. The company also offers technologies such as SDR-Grafting, CDR-Grafting, ReSurfacing and Deimmunization. Aprogen also partners with Nichi-Iko for conducting research and development activities in the field of biosimilars. The company operates as a subsidiary of Schnell Biopharmaceuticals. Aprogen is headquartered in Daejeon, Korea.

Aprogen, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

Table Of Contents

Aprogen, Inc. - Pharmaceuticals and Healthcare - Deals and Alliances Profile
Table of Contents


Table of Contents 2

List of Tables
3

List of Figures
4
Aprogen, Inc., Pharmaceuticals and Healthcare, Deals By Year, 2009 to YTD 2015 5
Aprogen, Inc., Pharmaceuticals and Healthcare Deals By Type, 2009 to YTD 2015 6
Aprogen, Inc., Pharmaceuticals and Healthcare, Deals By Region, 2009 to YTD 2015 7
Aprogen, Inc., Pharmaceuticals and Healthcare, Deals By Therapy Area, 2009 to YTD 2015 8
Aprogen, Inc., Pharmaceuticals and Healthcare, Deals Summary, 2009 to YTD 2015 10
Aprogen, Inc., Pharmaceuticals and Healthcare, Deal Details 11
Partnerships 11
Binex Forms Joint Venture with Aprogen 11
Schnell BioPharma Enters Into Co-Development Agreement With Aprogen And Chunggei Pharm 12
Acquisition 13
Huacheng Travel Agency Plans to Acquire Schnell Biopharma 13
Gbase to Acquire 22% Stake in Aprogen for USD16 Million 14
Binex Completes Acquisition of 22% Stake in Aprogen for USD14 million 15
Nichi-iko Pharma Acquires 33.4% Stake In Aprogen 17
Schnell BioPharma Acquires Aprogen 19
Aprogen, Inc. - Key Competitors 20
Locations And Subsidiaries 20
Head Office 20
Appendix 21
Methodology 21
About GlobalData 21
Contact Us 21
Disclaimer 21


List of Tables

Aprogen, Inc., Pharmaceuticals and Healthcare, Key Facts 1
Aprogen, Inc., Pharmaceuticals and Healthcare, Deals By Year, 2009 to YTD 2015 5
Aprogen, Inc., Pharmaceuticals and Healthcare Deals By Type, 2009 to YTD 2015 6
Aprogen, Inc., Pharmaceuticals and Healthcare, Deals By Region, 2009 to YTD 2015 7
Aprogen, Inc., Deals By Therapy Area, 2009 to YTD 2015 8
Aprogen, Inc., Pharmaceuticals and Healthcare, Deals Summary, 2009 to YTD 2015 10
Binex Forms Joint Venture with Aprogen 11
Schnell BioPharma Enters Into Co-Development Agreement With Aprogen And Chunggei Pharm 12
Huacheng Travel Agency Plans to Acquire Schnell Biopharma 13
Gbase to Acquire 22% Stake in Aprogen for USD16 Million 14
Binex Completes Acquisition of 22% Stake in Aprogen for USD14 million 15
Nichi-iko Pharma Acquires 33.4% Stake In Aprogen 17
Schnell BioPharma Acquires Aprogen 19
Aprogen, Inc., Key Competitors 20


List of Figures

Aprogen, Inc., Pharmaceuticals and Healthcare, Deals by Type, 2009 to YTD 2015 1
Aprogen, Inc., Pharmaceuticals and Healthcare, Deals By Year, 2009 to YTD 2015 1
Aprogen, Inc., Pharmaceuticals and Healthcare, Deals By Region, 2009 to YTD 2015 1
Aprogen, Inc., Pharmaceuticals and Healthcare, Deals By Therapy Area, 2009 to YTD 2015 1
Aprogen, Inc., Pharmaceuticals and Healthcare, Deals By Year, 2009 to YTD 2015 5
Aprogen, Inc., Pharmaceuticals and Healthcare, Deals by Type, 2009 to YTD 2015 6
Aprogen, Inc., Pharmaceuticals and Healthcare, Deals By Region, 2009 to YTD 2015 7
Aprogen, Inc., Pharmaceuticals and Healthcare, Deals By Therapy Area, 2009 to YTD 2015 8

Companies Mentioned

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.